- In October 2022, Illumina, Inc. and AstraZeneca established a strategic research collaboration to accelerate therapeutic target discovery by integrating AI-based genome interpretation with genomic analysis tools, enhancing confidence in drug target identification through human omics insights
- In September 2022, Thermo Fisher Scientific became a founding sponsor of the Pennsylvania Biotechnology Center (PABC), supporting both the Philadelphia-based B+Labs incubator and the PABC site in Doylestown, Pennsylvania, to help life science startups accelerate commercialization
- In June 2022, LatchBio introduced an end-to-end bioinformatics platform for managing large-scale biotech data, aiming to streamline scientific discovery and enhance research efficiency
- In March 2022, ARUP unveiled Rio, a bioinformatics pipeline and analytics platform, designed to improve the speed and accuracy of next-generation sequencing (NGS) test results
- In January 2021, BGI expanded its collaboration with the Ministry of Health of Brunei to enhance public health initiatives, including emergency response, diagnostic screening, personalized medicine, and early cancer detection through advanced sequencing technology
